9
Total investments
3
Early stage
1
Mid stage
0
Late stage
27y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Growth investor
2015
Stomping Ground is a Melbourne brewery bringing people from all walks together over a great beer.
A century ago Collingwood was the epicentre of Australian brewing, and breweries were an integral part of their community. We’re proud to bring independent brewing back to its original stomping ground - and put our community at the heart of everything we do. Beer should be for everyone and we brew award-winning beers to suit all tastes, from laid-back easy drinkers to the adventurous.
Whether it’s at one of our Beer Halls in Collingwood, Morris Moor or Melbourne Airport, or at one of our city’s iconic bars or pubs, start your beer journey wherever you're at, and we’ll take you wherever you want to go.
Buyout investor
2014
Asaleo Care, an Essity company is a leader in personal care and hygiene products across Australasia. Many of our well recognised brands have been in the market for over 60 years and are used daily in households and businesses across Australia, New Zealand, Fiji and the Pacific. Our portfolio of market leading brands include Libra, TENA and Tork in Australia, Purex, Handee, Sorbent in New Zealand and Viti and Orchard in the Pacific Islands.
We manufacture and sell essential everyday consumer products across feminine, incontinence and baby care, consumer tissue and professional hygiene product categories. Our manufacturing footprint extends across Australia, New Zealand and Fiji with 15 manufacturing and distribution sites. Our head office is located in Springvale, Victoria, Australia.
At Essity, we believe everyone's learning and professional development is unique and want to empower employees to reach their full potential in a winning culture motivated by a powerful purpose.
Collaborative and Inclusive Culture | Empowering & Engaged Leaders | Working with Powerful Purpose & Sustainable Impact | Learning and Growing in your Career | Supporting Well-being & Sustainable Working Life | Life-changing Innovations | Competitive Total rewards
Together, we are improving lives, every day.
Working at Essity is not just a career; it is a chance to directly make the world a healthier, more hygienic and safer place. With impactful innovations coupled with sustainable solutions, we strive to reach more people every year with the necessary and essential solutions for well-being.
Seed investor
2013
Kodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiaks discovery engine. Kodiaks lead product candidate, tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development. KSI-501 is our dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases. We are expanding our early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma.
WORKING AT KODIAK
We foster a culture of curiosity, creativity, compassion and courage. Our collective goal is to make a difference in the world. We do that as a team driven by the shared desire to tackle some of the world’s biggest challenges. If this sounds exciting, we want to hear from you!
Kodiak supports a vibrant and active lifestyle, striving to provide an optimal work-life balance. We are located in Palo Alto, in the heart of the world-class biotech hub of Silicon Valley, and within walking distance to California Avenue’s shops, restaurants and public transportation.
Seed investor
Jan 2011
Betashares is a leading Australian fund manager specialising in exchange traded funds (ETFs) and other funds traded on the Australian Securities Exchange (ASX).
Since launching our first ETF in 2010, Betashares has grown to become one of Australia’s largest managers of ETFs.
Serving over a million Australian investors, Betashares offers cost-effective, simple and liquid access to the broadest range of ETF investment solutions available on the ASX, covering almost every asset class and investment strategy.
As of April 2024, Betashares manages approximately $37 billion in assets.
Visit our website, YouTube channel and social channels for expert tips and insights.
Website: www.betashares.com.au
Instagram - https://www.instagram.com/betashares/
YouTube - https://www.youtube.com/@betasharesexplains
Facebook - https://www.facebook.com/BetasharesETFs
Buyout investor
2004
Warner Music Group (WMG) brings together artists, songwriters, entrepreneurs, and technology that are moving entertainment culture across the globe. Operating in more than 70 countries through a network of affiliates and licensees, WMG’s Recorded Music division includes renowned labels such as 10K Projects, 300 Entertainment, Asylum, Atlantic, Big Beat, EastWest, Elektra, Erato, First Night, Fueled By Ramen, Nonesuch, Parlophone, Reprise, Rhino, Roadrunner, Sire, Spinnin’, Warner Records, Warner Classics, and Warner Records Nashville. WMG’s music publishing arm, Warner Chappell Music, has a catalog of over one million copyrights spanning every musical genre, from the standards of the Great American Songbook to the biggest hits of the 21st century. Warner Music Group is also home to ADA, which supports the independent community, as well as artist services division WMX.
Buyout Investor
2003
In a world that never stands still – where the nature of risk is constantly evolving and the needs of your customers are continually changing – you need a partner that turns challenges into possibilities and possibilities into opportunities. A specialty insurer and reinsurer that elevates beyond the standard solutions. We help customers pursue their ambitions and explore new pathways through tailored products and services, on a global scale. A partner that you can trust – and who is with you for the journey.
Our strength is grounded in our people and our culture, which encourages collaboration, diversity, and accountability.
A values-driven organization, we strive to leave a positive imprint on the world through responsible business practices.
This is who we are. This is AXIS.
Investor
1999
ModusLink Corporation, a wholly-owned subsidiary of Steel Connect, Inc. (NASDAQ: STCN), provides digital and physical supply chain solutions to many of the world’s leading brands across a diverse range of industries, including consumer electronics, telecommunications, computing and storage, software and content, consumer packaged goods, medical devices, retail and luxury and connected devices. With a global footprint spanning North America, Europe and the Asia Pacific, the Company’s solutions and services are designed to improve end-to-end supply chains in order to drive growth, lower costs, and improve profitability.
For details on ModusLink Corporation’s solutions visit www.moduslink.com<http://www.moduslink.com
Experience · 12 entries
All (12)
Investments (9)
2022
Managing Director
Dec 2022
We aspire to be the world’s most exceptional financial institution, united by our shared values of partnership, client service, integrity, and excellence.
Operating at the center of capital markets, we act as one firm, mobilizing our people, capital, and ideas to deliver superior results across our clients’ most complex challenges.
For 157 years, Goldman Sachs has delivered world-class execution on a global scale across our leading Global Banking & Markets and Asset & Wealth Management businesses.
Apprenticeship is central to our culture, with hands-on coaching and access to leaders who bring decades of experience and expertise. With office locations around the world, we offer a broad range of career opportunities to those who insist on excellence and thrive on performance.
Find our Social Media Disclosures here: gs.com/social-media-disclosures
2015
Growth investor
2015
Stomping Ground is a Melbourne brewery bringing people from all walks together over a great beer.
A century ago Collingwood was the epicentre of Australian brewing, and breweries were an integral part of their community. We’re proud to bring independent brewing back to its original stomping ground - and put our community at the heart of everything we do. Beer should be for everyone and we brew award-winning beers to suit all tastes, from laid-back easy drinkers to the adventurous.
Whether it’s at one of our Beer Halls in Collingwood, Morris Moor or Melbourne Airport, or at one of our city’s iconic bars or pubs, start your beer journey wherever you're at, and we’ll take you wherever you want to go.
2014
Buyout investor
2014
Asaleo Care, an Essity company is a leader in personal care and hygiene products across Australasia. Many of our well recognised brands have been in the market for over 60 years and are used daily in households and businesses across Australia, New Zealand, Fiji and the Pacific. Our portfolio of market leading brands include Libra, TENA and Tork in Australia, Purex, Handee, Sorbent in New Zealand and Viti and Orchard in the Pacific Islands.
We manufacture and sell essential everyday consumer products across feminine, incontinence and baby care, consumer tissue and professional hygiene product categories. Our manufacturing footprint extends across Australia, New Zealand and Fiji with 15 manufacturing and distribution sites. Our head office is located in Springvale, Victoria, Australia.
At Essity, we believe everyone's learning and professional development is unique and want to empower employees to reach their full potential in a winning culture motivated by a powerful purpose.
Collaborative and Inclusive Culture | Empowering & Engaged Leaders | Working with Powerful Purpose & Sustainable Impact | Learning and Growing in your Career | Supporting Well-being & Sustainable Working Life | Life-changing Innovations | Competitive Total rewards
Together, we are improving lives, every day.
Working at Essity is not just a career; it is a chance to directly make the world a healthier, more hygienic and safer place. With impactful innovations coupled with sustainable solutions, we strive to reach more people every year with the necessary and essential solutions for well-being.
2013
Seed investor
2013
Kodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiaks discovery engine. Kodiaks lead product candidate, tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development. KSI-501 is our dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases. We are expanding our early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma.
WORKING AT KODIAK
We foster a culture of curiosity, creativity, compassion and courage. Our collective goal is to make a difference in the world. We do that as a team driven by the shared desire to tackle some of the world’s biggest challenges. If this sounds exciting, we want to hear from you!
Kodiak supports a vibrant and active lifestyle, striving to provide an optimal work-life balance. We are located in Palo Alto, in the heart of the world-class biotech hub of Silicon Valley, and within walking distance to California Avenue’s shops, restaurants and public transportation.
2011
Seed investor
Jan 2011
Betashares is a leading Australian fund manager specialising in exchange traded funds (ETFs) and other funds traded on the Australian Securities Exchange (ASX).
Since launching our first ETF in 2010, Betashares has grown to become one of Australia’s largest managers of ETFs.
Serving over a million Australian investors, Betashares offers cost-effective, simple and liquid access to the broadest range of ETF investment solutions available on the ASX, covering almost every asset class and investment strategy.
As of April 2024, Betashares manages approximately $37 billion in assets.
Visit our website, YouTube channel and social channels for expert tips and insights.
Website: www.betashares.com.au
Instagram - https://www.instagram.com/betashares/
YouTube - https://www.youtube.com/@betasharesexplains
Facebook - https://www.facebook.com/BetasharesETFs
Show all 12 entries ↓
Investment activity
1999–2015 · 9 investments
Recent (last 2 years)Earlier
